Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) EBT Margin (2020 - 2025)

Historic EBT Margin for Biofrontera (BFRIW) over the last 6 years, with Q3 2025 value amounting to 95.06%.

  • Biofrontera's EBT Margin fell 321900.0% to 95.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 47.22%, marking a year-over-year decrease of 109700.0%. This contributed to the annual value of 47.53% for FY2024, which is 115200.0% up from last year.
  • According to the latest figures from Q3 2025, Biofrontera's EBT Margin is 95.06%, which was down 321900.0% from 58.73% recorded in Q2 2025.
  • Biofrontera's 5-year EBT Margin high stood at 57.34% for Q1 2022, and its period low was 369.31% during Q3 2021.
  • Its 5-year average for EBT Margin is 74.5%, with a median of 61.78% in 2021.
  • As far as peak fluctuations go, Biofrontera's EBT Margin tumbled by -2794000bps in 2021, and later soared by 3099600bps in 2022.
  • Quarter analysis of 5 years shows Biofrontera's EBT Margin stood at 158.16% in 2021, then soared by 83bps to 27.44% in 2022, then surged by 221bps to 33.22% in 2023, then crashed by -134bps to 11.14% in 2024, then tumbled by -753bps to 95.06% in 2025.
  • Its last three reported values are 95.06% in Q3 2025, 58.73% for Q2 2025, and 48.95% during Q1 2025.